NSC309874, which did not significantly interact with the PDGFRβ G4 structures, repressed PDGFRβ transcription in an aggressive neuroblastoma cell line indicating the potential of this compound as a new PDGFRβ inhibitor. Here, PDGFRB is linked to neuroblastoma.